About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

American Kidney Fund Hosts Annual National Summit on Unknown Causes of Kidney Disease

By: via GlobeNewswire

ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- As part of its ongoing groundbreaking work to advance understanding and patient care of undiagnosed or misdiagnosed causes of kidney disease, the American Kidney Fund (AKF) will convene nearly 100 medical and industry leaders together with patient advocates on Tuesday for the fifth annual national summit of its Unknown Causes of Kidney Disease (UCKD) Project in Washington, DC. 

Launched by AKF in November 2020, the UCKD Project works to expand access to genetic testing, reduce systemic inequities, engage providers and empower patients. Implementation groups have concentrated their work in three areas: public policy, patients and caregivers, and health care professionals. 

“About 1 in 7 American adults has kidney disease, and we estimate that up to 15% don’t know the cause of their kidney disease,” said LaVarne A. Burton, AKF President and CEO. “That’s a significant number of people living without concrete answers about why they were diagnosed with a life-altering chronic disease, and whose kidney disease journeys may include multiple treatment plans until they get the right diagnosis. The work of the UCKD Project is playing a vital role in improving health outcomes for all those affected by rare or undiagnosed kidney disease. This progress wouldn’t be possible without the patient advocates, heath care providers, researchers and industry leaders who have worked with us on this initiative.” 

A survey administered by AKF in 2022 showed health care providers find diagnosing and treating kidney disease more challenging when it is not associated with common causes of Type 2 diabetes and hypertension, reinforcing opportunities to expand professional education in areas such as rare kidney diseases and genetic testing. 

To that end, following AKF’s highly successful online continuing medical education courses, this year’s UCKD Summit will focus in part on educational efforts targeting community physicians, particularly those at small practices and those who serve suburban and rural areas. Earlier this year, AKF announced the expansion of its Know Your Kidneys™ program, which has three learning pathways including Know Your Cause, which offers information about testing options, finding a genetic counselor and an interactive tool to guide patients on talking to their doctor about identifying the cause of their kidney disease. 

The keynote speaker at the summit is Meredith A. Schanda, chief operating officer of the MAVEN Project. Schanda will discuss how the MAVEN Project is using telehealth to improve patient outcomes and access to care for vulnerable populations. 

Speakers at the summit also include Kevin Schnurr, managing director of the Alport Syndrome Foundation; AKF Ambassadors Nichole Jefferson and Emani McConnell-Brent; Jill Goodrich, co-executive director of the Dent Disease Foundation; Gillian Hooker, chief scientific officer at Concert; and Dr. Ali Poyan Mehr, founding president of the GlomCon Foundation.

Many participants of the UCKD Summit this year are members of AKF’s recently established Rare Kidney Disease Action Network. They will also participate in AKF’s Rare Kidney Disease Advocacy Day on Capitol Hill on Sept. 18, during which they will ask their members of Congress to support the Access to Genetic Counselors Services Act (H.R. 3876/S. 2323) and the New Era of Preventing End-Stage Kidney Disease Act (H.R. 6790). 

AKF is grateful to its corporate sponsors whose support makes the UCKD Summit possible: Title Sponsors Novartis Pharmaceuticals Corporation and Travere Therapeutics; Leadership Sponsors Otsuka America Pharmaceutical, Inc. and Vertex Pharmaceuticals Inc.; Champion Sponsors Alexion, AstraZeneca Rare Disease; Boehringer Ingelheim; Natera; Novo Nordisk and Sanofi. 

###

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nonprofit with the greatest direct impact on people with kidney disease. AKF works on behalf of 1 in 7 Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. AKF fights for kidney health for all through programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator for 21 consecutive years and the Platinum Seal of Transparency from Candid, formerly known as GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org

More News

View More
FICO’s Big Dip Could Be the Best Buying Chance of the Year
Via MarketBeat
Tickers EFX FICO
D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Via MarketBeat
Tickers QBTS RGTI
Datavault: A Speculative AI Play, But Beware of Volatility
Via MarketBeat
Topics Artificial Intelligence
Tickers DVLT IBM SCLX
Traders Are Piling Into Suncor Call Options—Should You?
Via MarketBeat
Topics World Trade
Tickers SU
Delta Air Lines Stock Looks Ready to Fly to New Highs
Via MarketBeat
Tickers DAL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.